Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel I Martin

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Medchemcomm|October 6, 2018
β-lactam/β-lactamase inhibitor combinations: an updateKamaleddin H M E Tehrani, Nathaniel I Martin
ACS Infectious Diseases|July 27, 2022
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022Emma van Groesen, Paolo Innocenti, Nathaniel I Martin
Journal of Medicinal Chemistry|July 20, 2021
A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative PathogensThomas M Wood, Cornelis J Slingerland, Nathaniel I Martin
Methods (San Diego, Calif.)|August 18, 2019
Peptidic transition state analogues as PRMT inhibitorsYurui Zhang, Matthijs J van Haren, Nathaniel I Martin
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1Nathaniel I Martin, Emily R Derbyshire, Michael A Marletta
Biochimica Et Biophysica Acta. Biomembranes|January 13, 2024
The enigmatic mode of action of the lantibiotic epilancin 15XXiaoqi Wang, Yang Xu, Nathaniel I Martin, et al.
Nature Methods|December 26, 2006
An Escherichia coli expression-based method for heme substitutionJoshua J Woodward, Nathaniel I Martin, Michael A Marletta
Organic Letters|August 25, 2006
NG-hydroxyguanidines from primary aminesNathaniel I Martin, Joshua J Woodward, Michael A Marletta
Drug Discovery Today|May 24, 2021
Nicotinamide N-methyl transferase (NNMT): An emerging therapeutic targetYongzhi Gao, Nathaniel I Martin, Matthijs J van Haren
Nature Reviews. Microbiology|October 14, 2025
Bacterial cell envelope-targeting antibioticsCharalampos Ntallis, Nathaniel I Martin, Andrew M Edwards, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Medchemcomm|October 6, 2018
β-lactam/β-lactamase inhibitor combinations: an updateKamaleddin H M E Tehrani, Nathaniel I Martin
ACS Infectious Diseases|July 27, 2022
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022Emma van Groesen, Paolo Innocenti, Nathaniel I Martin
Journal of Medicinal Chemistry|July 20, 2021
A Convenient Chemoenzymatic Preparation of Chimeric Macrocyclic Peptide Antibiotics with Potent Activity against Gram-Negative PathogensThomas M Wood, Cornelis J Slingerland, Nathaniel I Martin
Methods (San Diego, Calif.)|August 18, 2019
Peptidic transition state analogues as PRMT inhibitorsYurui Zhang, Matthijs J van Haren, Nathaniel I Martin
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1Nathaniel I Martin, Emily R Derbyshire, Michael A Marletta
Biochimica Et Biophysica Acta. Biomembranes|January 13, 2024
The enigmatic mode of action of the lantibiotic epilancin 15XXiaoqi Wang, Yang Xu, Nathaniel I Martin, et al.
Nature Methods|December 26, 2006
An Escherichia coli expression-based method for heme substitutionJoshua J Woodward, Nathaniel I Martin, Michael A Marletta
Organic Letters|August 25, 2006
NG-hydroxyguanidines from primary aminesNathaniel I Martin, Joshua J Woodward, Michael A Marletta
Drug Discovery Today|May 24, 2021
Nicotinamide N-methyl transferase (NNMT): An emerging therapeutic targetYongzhi Gao, Nathaniel I Martin, Matthijs J van Haren
Nature Reviews. Microbiology|October 14, 2025
Bacterial cell envelope-targeting antibioticsCharalampos Ntallis, Nathaniel I Martin, Andrew M Edwards, et al.
Pageof 15